Bracket, a clinical trial specialty services provider, has announced the addition of Jeffrey W. Kinell as CEO and new member of its board of directors.
Kinell brings more than 30 years of experience to Bracket, primarily in leadership positions in growth-oriented health services and pharmaceutical outsourcing firms. Most recently, he was CEO of CRI Lifetree, a mid-sized specialized research organization focused in early phase clinical development. During his five-year tenure, Kinell oversaw the firm’s transformation into a scientifically driven organization offering highly specialized capabilities across multiple therapeutic areas.
“Jeff intimately understands the pharma/biotech specialty clinical space and the unique demands of clinical trials in multiple therapeutic areas and across multiple study phases,” said David G. Daniel, M.D., Bracket senior vice president and chief medical director. “This, combined with his broad experience across science, technology and operations, makes him the perfect fit for Bracket, especially as we continue to innovate and grow as an independent, privately held company.”
Jim Primerano, Bracket senior vice president and general manager for the eClinical group, said, “Jeff’s experience and leadership will be invaluable to our existing team, and Bracket and our clients are going to benefit greatly from his years of providing dynamic solutions to the biopharmaceutical market. He has a true commitment to innovative products and a unique perspective from actually dealing with the practical challenges of implementing technology solutions in a clinical environment. He sees the obvious benefits of adopting technology solutions in clinical trials to create efficiencies and improve quality.”
Bracket partners with sponsors and CROs to achieve greater certainty and accurate outcomes in their clinical trials by providing a combination of scientific, technological and operational support, from phase I to post approval. Bracket is a member of the Electronic Patient-Reported Outcome (ePRO) Consortium, a program of the Critical Path Institute (C-Path), which collaborates in a non-competitive, neutral environment to develop guidelines and advance the quality of electronic data collection methods for PROs. Bracket operates in the U.S., U.K., Continental Europe and Japan.